Inflammation and cancer: A comparative view

Journal of Veterinary Internal Medicine

Volumn 26, Issue 1, 2012, Pages 18-31

  Morrison, Wallace B ^a  

^a PURDUE UNIVERSITY   (United States)

Author keywords

Cancer; Comparative; Infection; Inflammation; Tumor

Indexed keywords

ANIMAL; COMPARATIVE STUDY; HUMAN; INFLAMMATION; NEOPLASM; PATHOLOGY; REVIEW;

ANIMALS; HUMANS; INFLAMMATION; NEOPLASMS;

BACTERIA (MICROORGANISMS);

EID: 84855720904     PISSN: 08916640     EISSN: 19391676     Source Type: Journal    
DOI: 10.1111/j.1939-1676.2011.00836.x     Document Type: Review

References (152)

1. Balkwill F, Mantovani A. Inflammation and cancer: Back to Virchow? Lancet 2001;357:539-545.
2. Hussain SP, Harris CC. Inflammation and cancer: An ancient link with novel potentials. Int J Cancer 2007;121:2373-2380.
3. Okada F. Beyond foreign-body induced carcinogenesis: Impact of reactive oxygen species derived from inflammatory tumorigenic conversion and tumor progression. Int J Cancer 2007;121:2364-2372.
4. Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature 2008;454:436-444.
5. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002;454:860-867.
6. Smith GR, Missailidis S. Cancer, inflammation and the AT1 and AT2 receptors. J Inflammation 2004;11:1-3.
7. Lu H, Ouyang W, Huang C. Inflammation, a key event in cancer development. Mol Cancer Res 2006;4:221-233.
8. Shacter E, Weitzman SA. Chronic inflammation and cancer. Oncology 2002;16:217-232.
9. National Cancer Institute Division of Cancer biology. Bethesda: Executive summary of inflammation and cancer think tank. Available at: pages73-78. Accessed October 28, 2011.
10. Federico A, Morgillo F, Tuccillo C, et al. Chronic inflammation and oxidative stress in human carcinogenesis. Int J Cancer 2007;121:2381-2386.
11. DeNardo DG, Coussens LM. Inflammation and breast cancer. Balancing immune response: Crosstalk between adaptive and innate immune cells during breast cancer progression. Breast Cancer Res 2007;9:212-222.
12. Maeda S, Omata M. Inflammation and cancer: Role of nuclear factor -kappa B activation. Cancer Sci 2008;99:836-842.
13. Whitcomb DC. Inflammation and cancer V. Chronic pancreatitis and pancreatic cancer. Am J Physiol Gastrointest Liver Physiol 2004;287:315-319.
14. Riehl A, Németh J, Angel P, Hess J. The receptor RAGE: Bridging inflammation and cancer. J Cell Commun Sign 2009;7:12.
15. Rakoff-Nahoum S. Why cancer and inflammation? Yale J Biol Med 2006;79:123-130.
16. Conti A, Gulì C, La Torre D, et al. Role of inflammation and oxidative stress mediators in gliomas. Cancers 2010;2:693-712.
17. Mantovani A. Inflammation and cancer: The macrophage connection. Medicina 2007;67suppl 2:32-34.
18. Erdman SE, Poutahidis T. Cancer inflammation and regulatory T cells. In J Cancer 2010;127:768-779.
19. Verteramo R, Pierangeli A, Mancini E, et al. Human papillomaviruses and genital co-infections in gynaecological patients. BMC Infect Dis 2009 Feb 12 9:16 doi:10.1186/1471-2334-9-191 Available at: Accessed November 3, 2011.
20. Scheurer ME, Tortolero-Luna G, Adler-Storthz K. Human papillomavirus infection: Biology, epidemiology, and prevention. Int J Gynecol Cancer 2005;15:727-742.
21. Kovacic MB, Katki HA, Kreimer AR, Sherman ME. Epidemiologic analysis of histologic cervical inflammation: Relationship to human papillomavirus infections. Hum Pathol 2008;39:1088-1095.
22. Hawes SE, Kiviat NB. Are genital infections and inflammation cofactors in the pathogenesis of invasive cervical cancer? JNCI 2002;94:1592-1593.
23. Muñoz N, Castellsagué X, Berrington de González A, Gissmann L. Chapter 1: HPV in the etiology of human cancer. Vaccine 2006. 24S3 S3/1-S3/10. doi:10.1016/j.vaccine.2006.05.115.
24. Zur Hausen H. Papilloma viruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2002;2:342-350.
25. Ye FC, Zhou FC, Xie JP, et al. Kaposi's sarcoma-associated herpesvirus latent gene vFLIP inhibits viral lytic replication through NF-kB-mediated suppression of the AP-1 pathway: A novel mechanism of virus control of latency. J Virol 2008;82:4235-4249.
26. Sodhi A, Montaner S, Patel V, et al. The Kaposi's sarcoma-associated herpes virus G protein-coupled receptor up-regulates vascular endothelial growth factor expression and secretion through mitogen-activated protein kinase and p38 pathways acting on hypoxia-inducible factor 1α1. Cancer Res 2000;60:4873-4880.
27. Gasperini P, Sakakibara S, Tosato G. Contribution of viral and cellular cytokines to Kaposi's sarcoma-associated herpesvirus pathogenesis. J Leukocyte Boi 2008;84:994-1000.
28. Mercader M, Taddeo B, Panella JR, et al. Induction of HHV-8 lytic cycle replication by inflammatory cytokines produced by HIV-1-infected T cells. Am J Pathol 2000;156:1961-1971.
29. Thompson MP, Kurzrock R. Epstein-Barr virus and cancer. Clin Cancer Res 2004;10:803-821.
30. Pang M, Lin K, Peh S. The signaling pathways of Epstein Barr virus-encoded latent membrane protein 2A (LMP2A) in latency and cancer. Cell Mol Bio Lett 2009;14:222-247.
31. Michaelis M, Doerr HW, Cinatl J Jr. The story of human cytomegalovirus and cancer: Increasing evidence and open questions. Neoplasia 2009;11:1-9.
32. Azam F, Koulaouzidis A. Hepatitis B virus and hepatocarcinogenesis. Ann of Hepatol 2008;7:125-129.
33. Bogenberger JM, Laybourn PJ. Human T lymphotrhphic virus type 1 protein tax reduces histone levels. Retrovirology 2008;5:9 doi:10.1186/1742-4690-5-9.
34. Verdonck K, González E, Van Dooren S, et al. Human T-lymphotrophic virus 1: Recent knowledge about an ancient infection. Lancet 2007;7:266-281.
35. Kondo R, Higuchi M, Takahashi M, et al. Human T-cell leukemia vurus type 2 Tax protein induces interleukin 2-independent growth in a T-cell line. Retrovirology 2006 Dec 2;3:88 doi:10.1186/1742-4690-3-88.
36. Meria LB, Bugni JM, Green SL, et al. DNA damage induced by chronic inflammation contributes to colon carcinogenesis in mice. J Clin Invest 2008;118:2516-2525.
37. Chiba T, Marusawa H, Seno H, Watanabe N. Mechanism for gastric cancer development by Helicobacter pylori infection. J Gastroenterol Hepatol 2008;23:1175-1181.
38. Suki M, Mimuro H, Kiga K, et al. Helicobacter pylori CagA phosphorylation-independent function in epithelial proliferation and inflammation. Cell Host Mocrobe 2009;5:23-34.
39. Risch HA, Yu H, Lu L, Kidd MS. ABO blood group, Helicobacter pylori seropositivity, and risk of pancreatic cancer: A case-control study. J Natl Cancer Inst 2010;102:502-505.
40. De Martel C, Llosa AE, Friedman GD, et al. Helicobacter pylori infection and development of pancreatic cancer. Cancer Epidemiol Biomarkers Prev 2008;17:1188-1194.
41. Palumbo E. Association between schistosomiasis and cancer: A review. Infect Dis Clin Pract 2007;15:145-148.
42. King CT. Toward the elimination of schistosomiasis. N Engl M Med 2009;360:106-109.
43. Bacelar A, Castro LGMC, de Queiroz AC, Café E. Association between prostate cancer and schistosomiasis in young patients: A case report and literature review. Braz J Infect Dis 2007;11:5520-5522.
44. Watanapa P, Watanapa WB. Liver fluke-associated cholangiocarcinoma. Br J Surg 2002;89:962-970.
45. National Institute of Allergy and Infectious Diseases. Pathogenesis of liver fluke induced cancer in Thailand 2007. Available at Cited 9/8/10.
46. Lim MK, Ju Y-H, Franceschi S, et al. Clonorchis sinensis infection and increasing risk of cholangiocarcinoma in the Republic of Korea. Am J Trop Med Hyg 2006;75:93-96.
47. Das PR, Singal R. DNA methylation and cancer. J Clin Oncol 2004;22:4632-4642.
48. Antonsson A, Nancarrow DJ, Brown IS, et al. High-risk human popillomavirus in esophageal squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 2010;19:2080-2087.
49. Antman KH. Malignant mesothelioma. N Engl J Med 1980;303:200-202.
50. Kilburn KH, Warshaw R, Thornton JC. Asbestosis, pulmonary symptoms and functional impairment in shipyard workers. Chest 1985;88:254-259.
51. Churg A, Wiggs B. Fibersize and number in amphibole asbestos-induced mesothelioma. Am J Pathol 1984;115:437-442.
52. Hull MJ, Abraham JL, Case BW. Mesothelioma among workers in asbestiform fiber-bearing talc mines in New York State. Ann occup Hygine 2002;46Suppl 1:132-135.
53. Jaurand M F, Renier Am, Daubriac J. Mesothelioma: Do asbestos and carbon nanotubes pose the same health risk? Particle Fibre Tox 2009;6:16-30.
54. Nyrén O, McLaughlin JK, Gridley G, et al. Cancer risk after hip replacement with metal implants: A population based cohort study in Sweden. JNCI 1995;87:28-33.
55. Copcu E. Marjolin's ulcer: A preventable complication of burns? Plastic Reconstructive Surg 2009;124:156e-164e.
56. Lindelöf B, Krynitz B, Granath F, Ekbom A. Burn injuries and skin cancer: A population-based cohort study. Acta Derm Venereol 2008;88:20-22.
57. Kowal-Vern A, Criswell BK. Burn scar neoplasms: A literature review and statistical analysis. Burns 2005;31:403-313.
58. Cleaver JE, Mitchell DL. Ultraviolet radiation carcinogenesis. In: Holland JF, Frei E, Bast RC, et al. eds. 3rd ed. Cancer Medicine. Philadelphia, PA: Lea & Febiger 1993:245-255.
59. Pedersen-Bjergaard J, Ersbøll J, Hansen VL, et al. Carcinoma of the urinary bladder after treatment with cyclophosphamide for non-Hodgkins lymphoma. N Engl J Med 1988;318:1028-1032.
60. Brown T. Silica exposure, smoking, silicosis and lung cancer - complex interactions. Occupational Med 2009;59:89-95.
61. Lindeman G, McKay MJ, Taubman KL, Bilous AM. Malignant fibrous histiocytoma developing in bone 44 years after shrapnel trauma. Cancer 1990;66:2229-2232.
62. Schumacher J, Watkins JP, Wilson SR, Foreman ME. Burn-induced neoplasia in two horses. Equine Vet J 1986;18:410-412.
63. Patel M, Silverstein S, Alexander LL. Epidermoid carcinoma subsequent to a gunshot wound of the face. J Nat Med Assoc 1984;76:1027-1029.
64. Gillis L, Lee S. Cancer as a sequel to war wounds. J Bone Joint Surg 1951;33B:167-179.
65. Avery PR, Avery AC. Molecular methods to distinguish reactive and neoplastic lymphocyte expansions and their importance in transitional neoplastic states. Vet Clin Pathol 2004;33:196-207.
66. Griffey SM, Kraegel SA, Madewell BR. Rapid detection of K-ras gene mutations in canine lung cancer using single-strand conformational polymorphism analysis. Carcinogenesi 1998;19:959-963.
67. Gramer I, Leidolf R, Döring B, et al. Breed distribution of the nt230(del4) MDR1 mutation in dogs. Vet J 2011;189(1):67-71.
68. Martinez M, Modric S, Sharkey M, et al. The pharmacogenomics of P-glycoprotein and its role in veterinary medicine. J Vet Pharmacol Therap 2008;31:285-300.
69. McEntee MF, Cates JM, Neilsen N. Cyclooxygenase-2 expression in spontaneous intestinal neoplasia of domestic dogs. Vet Pathol 2002;39:428-236.
70. Barnhart KF, Wojcieszyn J, Storts RW. Immunohistochemical staining patterns of canine meningiomas and correlation with published immunophenotypes. Vet Pathol 2002;39:311-321.
71. Ramos-Vera JA, Miller MA, Johnson GC, et al. Melan A and S100 protein immunohistochemistry in feline melanomas: 48 cases. Vet Pathol 2002;39:127-132.
72. Dias Pereira P, Lopes CC, Matos AJF, et al. Cox-2 expression in canine normal and neoplastic mammary gland. J Comp Pathol 2009;140:247-253.
73. Beam SL, Rassnick KM, Moore AS, McDonough SP. An immunohistochemical study of cyclooxygenase-2 expression in various feline neoplasms. Vet Pathol 2003;40:496-500.
74. Heller DA, Clifford CA, Goldschmidt MH, et al. Assessment of cyclooxygenase-2 expression in anine hemangiosarcoma, histiocytic sarcoma, and mast cell tumor. Vet Pathol 2005;42:350-353.
75. Kahn KNM, Stanfield KM, Trajkovic D, et al. Expression of cyclooxygenase-2 in canine renal cell carcinoma. Vet Pathol 2001;38:116-119.
76. Paolini M, Davis S, Lana S, et al. Canine tumor cross-species genomics uncovers targets linked to osteosarcoma progression. BMC Genomics 2009;10:625. Doi:10.1186/1471-2164-10-625 Available at: Accessed November 3, 2011.
77. Modiano JF, Breen M. Shared pathogenesis of human nad canine tumors- an inextricable link between cancer and evolution. Cancer Therapy 2008;6:239-246.
78. Millanta F, Citi S, Della Santa D, et al. COX-2 expression in canine and feline invasive mammary carcinomas: Correlation with clinicopathological features and prognostic molecular markers. Breast Cancer Res Treat 2006;98:115-120.
79. Gillet N, Florins A, Boxus M, et al. Mechanism of leukemogenesis induced by bovine leukemia virus: Prospects for novel anti-retroviral therapies in human. Retrovirology 2007 4:18 doi:10.1186/1742-4690-4-18. Available at: Accessed November 3, 2011.
80. Munday JS, Kiupel M. Papillomavirus-associated cutaneous neoplasia in mammals. Vet Pathol 2009;47:254-264.
81. Schulman FY, Krafft AE, Janczewski T. Feline cutaneous fibropapillomas: Clinicopathological findings and association with papillomavirus infection. Vet Pathol 2001;38:291-296.
82. Hanna PE, Dunn D. Cutaneous fibropapilloma in a cat (feline sarcoid). Can Vet J 2003;44:601-602.
83. Roperto S, Ambrosio V, Borzacchiello G, et al. Bovine papillomavirus type-2 (BPV-2) infection aned expression of uroplakin lllb, a novel urothelia cell marker in urinary bladder tumors of cows. Vet Pathol 2005;42:812-818.
84. Borzacchiello G, Ambrosio V, Roperto S, et al. Bovine papilloma virus type 4 in oesophageal papillomas of cattle from the south of Italy. J Comp Pathol 2003;128:203-206.
85. Borzacchiello G, Roperto F. Bovine papillomaviruses, papillomas and cancer in cattle. Vet Res 2008;39:45. doi: 10.1051/vetres:2008022 Available at: or Accessed November 3, 2011.
86. Chambers G, Ellsmore VA, O'Brien PM, et al. Association of bovine papillomavirus with equine sarcoid. J Gen Virol 2003;84:1055-1062.
87. Liu S-L, Miller AD. Oncogenic transformation by the Jaagsiekte sheep retrovirus envelope protein. Oncogene 2007;26:789-801.
88. Hudachek SF, Kraft SL, Thamm DH, et al. Lung tumor development and spontaneous regression in lambs coinfected with Jaagsiekte sheep retrovirus and ovine lentivirus. Vet Pathol 2010;47:148-162.
89. Leroux C, Girard N, Cottin V, et al. Jaagsiekte sheep retrovirus (jsrv):From virus to lung cancer in sheep. Vet Res 2007;38:211-228.
90. Maeda N, Fan H. Signal transduction pathways utilized by enzootic nasal tumor virus (ENTV-1) envelope protein in transformation of rat epithelial cells resemble those used by Jaagsiekte sheep retrovirus. Virus Genes 2008;36:147-155.
91. Dirks C, Duh FM, Rai SK, et al. Mechanism of cell entry and transformation by enzootic nasal tumor virus. J Virol 2002;76:2141-2149.
92. Caswell JL, Williams KJ. Respiratory system. In. Maxie MG, ed. Jubb, Kennedy, Palmer's Pathology of Domestic Animals 5th Edition. Edinburg: Elsevier-Health Sciences_Saunders Ltd. 2007:523-653.
93. Merezak C, Reichert M, Van Lint C, et al. Inhibition of histone deacetylases induces bovine leukemia virus expression in vitro and in vivo. J Virology 2002;76:5034-5042.
94. Hardy Jr WD. The feline leukemia virus. J Am Anim Hosp Assoc 1981;17:951-980.
95. Berry WL. Spirocerca lupi esophageal granulomas in 7 dogs: Resolution after treatment with doramectin. J Vet Intern Med 2000;14:1609-1612.
96. McEntee MC, Page RL. Feline vaccine-associated sarcomas. J Vet Intern Med 2001;15:176-182.
97. Hendrick MJ. Historical review and current knowledge of the risk factors involved in feline vaccine-associated sarcomas. J Am Vet Med Assoc 1998;213:1422-1423.
98. Morrison WB, Starr RM, Vaccine-Associated Feline Sarcoma Task Force. Vaccine-associated feline sarcomas. J Am Vet Med Assoc 2001;218:697-702.
99. Vaccine-Associated Feline Sarcoma Task Force: Roundtable Discussion. The current understanding and management of vaccine-associated sarcomas in cats. J Am Vet Med Assoc 2005;226(11):1821-1842.
100. Martano M, Morello E, Buracco XX. Feline injection -site sarcoma: past, present and future perspectives. Vet J 2011;188(2):136-141.
101. Hendrick MJ. Musings on feline injection site sarcomas. Vet J 2011;188(2):130-131.
102. Vascellari M, Melchiotti E, Bozza MA, Mutinelli F. Fibrorsarcomas at presumed sites of injection in dogs: Characteristics and comparison with non-vaccination site fibrosarcomas and feline post-vaccinal fibrosarcomas. Vet J Med 2003;50:286-291.
103. Munday JS, Stedman NL, Richey LJ. Histology and immunohistochemistry of seven ferret vaccination-site fibrosarcomas. Vet Pathol 2003;40:288-293.
104. Marsee DK, Williams JM, Velazquez EF. Aluminum granuloma after administration of the quadravalent human papilloma virus vaccine. Report of a case. Am J Dermatopathol 2008;30:622-624.
105. Rowland PH, Moise NS, Severson D. Myxoma at the site of a subcutaneous pacemaker in a dog. J Am Anim Hosp Assoc 1991;27:649-651.
106. Pardo AD, Adams WH, McCracken D, Legendre AM. Primary jejunal osteosarcoma associated with a surgical sponge. J Am Vet Med Assoc 1990;196:935-938.
107. Miller MA, Aper RL, Fauber A, et al. Extraskeletal osteosarcoma associated with a retained surgical sponge in a dog. J Vet Diagn Invest 2006;18:224-228.
108. Glickman LT, Domanski LM, Maguire TG, et al. Mesothelioma in pet dogs associated with exposure of their owners to asbestos. Enviro Res 1983;32:305-313.
109. Harbison ML, Godleski JJ. Malignant mesothelioma in urban dogs. Vet Path 1983;20:531-540.
110. Asbestosis.com. Types of asbestosis. Available at: Accessed September 15, 2010.
111. Fessler JF, Faber NA, Blevins WE, Coatney RW. Squamous cell carcinoma associated with a chronic wound in a horse. J Am Vet Med Assos 1992;202:615-616.
112. Rogers K, Barrington GM, Parish SM. Squamous cell carcinoma originating from a cutaneous scar in a llama. Can Vet J 1997;38:643-644.
113. Frazier K, Herron AJ, Dee J, et al. Development of a small-cell osteogenic sarcoma after ulnar ostectomy in a dog. J Am Vet Med Assoc 1991;198:432-434.
114. Miller WH, Shanley KJ. Bilateral pinnal squamous cell carcinoma in a dog with chronic otitis externa. Vet Derm 1991;2:37-39.
115. Li XQ, Hom DL, Black J, et al. Relationship between metallic implants and cancer: A case control study in a canine population. Vet Comp Orthop Traumatol 1993;6:70-74.
116. Gourley IM, Madewell BR, Barr BJ. Burn scar malignancy in a dog. J Am Vet Med Assoc 1982;180:1095-1097.
117. Baird AN, Frelier PF. Squamous cell carcinoma originating from an epithelial scar in a horse. J Am Vet Med Assoc 1990;196:1999-2000.
118. Hargis AM. A review of solar-induced lesions in domestic animals. Comp Cont Edu 1981;3:287-296.
119. Khan SG, Bickers DR, Mukhtar H, Agarwal R. Ras p21 farnesylation in ultraviolet B radiation-induced tumors in the skin of SKH -1 hairless mice. J Invest Dermatol 1994;102:754-758.
120. German AJ, Hall EJ, Day MJ. Chronic intestinal inflammation and intestinal disease in dogs. J Vet Intern Med 2003;17:8-20.
121. Waly NE, Gruffydd-Jones XX, Stokes CR, Day MJ. Immunohistochemical diagnosis of alimentary lymphomas and severe inflammation in cats. J Comp Pathol 2005;133:253-260.
122. Neravanda D, Kent M, Platt SR et al. Lymphoma-associated polymyositis in dogs. J Vet Intern Med 2009;23:1293-1298.
123. Knowles K. Neuromuscular case of the month-January 2001. University of California San Diego Comparative Neuromuscular Laboratory;2001.
124. Bennett Sl, Slocombe RF, Holloway SA, et al. Lymphoma(s) showing epithelioptrophism and diffuse skeletal muscle involvement presenting as a polymyopathy in a young dog. Aust Vet J 2005;83:612-615.
125. Kortz G. Neuromuscular case of the month-May 2003. University of California San Diego Comparative Neuromuscular Laboratory;2003.
126. Schatzberg SJ, Shelton GD. Newly identified neuromuscular disorders. Vet Clin North Am Small Anim Pract 2004;34:1497-1524.
127. Hakanson N, Shively JN, Reed RE, Merideth RE. Intraocular spindle cell sarcoma following ocular trauma in a cat: Case report and literature review. J Am Anim Hosp Assoc 1990;26:63-66.
128. Zeiss CJ, Johnson EM, Dubielzig RR. Feline intraocular tumors may arise from transformation of lens epithelium. Vet Pathol 2003;40:355-362.
129. Peterson JL, Couto CG, Hammer AS, Ayle RD. Acute sterile hemorrhagic cystitis after a single intravenous administration of cyclophosphamide in three dogs. J Am Vet Med Assos 1992;201:1572-1574.
130. Laing EJ, Miller CW, Cochrane SM. Treatment of cyclophosphamide induced hemorrhagic cystitis in five dogs. J Am Vet Med Assoc 1988;193:233-236.
131. Macy DW, Withrow SJ, Hoopes J. Transitional cell carcinoma of the bladder associated with cyclophosphamide administration. J Am Anim Hop Assoc 1983;19:965-969.
132. Weng YC, He F, Feng F, et al. Notch signaling determines the M1 versus M2 polarization of macrophages in antitumor immune responses. Cancer 2010;70:4840-4049.
133. Karin M. NF-K{green}B as a critical link between inflammation and cancer. Cold Spring Harb Perspect Biol 2009;1:a000141.
134. Peloponese Jr JM, Yeung ML, Jeang K-T. Modulation of nuclear factor-kB by human T cell leukemia virus type 1 tax protein: Implications for oncogenesis and inflammation. Immunologic Res 2006;34:1-12.
135. Nishikori M. Classical and alternative NF-kB actifation pathways and their roles in lymphoid malignancies. J Clin Exp Hematopathol 2005;45:15-24.
136. Dhillon AS, Hagan S, Rath O, Kolch W. MAP kinase signaling in cancer. Oncogene 2007;26:3279-3290.
137. Scaldaferri F, Vetrano S, Sans M, et al. VEGF-A links angiogenesis and inflammation in inflammatory bowel disease pathogenesis. Gastroenterology 2009;136:585-595.
138. Croll SD, Ransohoff RM, Cai N, et al. VEGF-mediated inflammation precedes angiogenesis in adult brain. Exp Neurol 2004;187:388-402.
139. Van de Bert PJ, Heutinck KM, Raabe R, et al. Human cytomegalovirus induces systemic activation characterized by aa type 1 cytokine. J Infect Dis 2010;202:690-699.
140. Parsonnet J, Isaacson PG, Path FRC. Bacterial infection and MALT lymphoma. N Eng J Med 2004;350:213-215.
141. Du M-Q, Isaccson PG. Gastric MALT lymphoma: From aetiology to treatment. Lancet Oncol 2002;3:997-104.
142. Wotherspoon AC. Gastric MALT lymphoma and Helicobacter pylori. Yale J Biol Med 2004;1:69.
143. Sakuma H, Nakamura T, Uemura N, et al. Immunoglobulin VH gene analysis in gastric MALT lymphomas. Modern Pathol 2007;20:460-466.
144. Freeman K, Woods E, Welsby S, et al. Biofilm evidence and the microbial diversity of horse wounds. Can J Microbiol 2009;55:197-202.
145. Clutterbuck AL, Woods EJ, Knottenbelt DC, et al. Biofilms and their relevance to veterinary medicine. Vet Microbio 2001;121:1-17.
146. Dowd SE, Sun Y, Secor PR, et al. Survey of bacterial diversity in chronic wounds using pyrosequencing, DGGE, and full ribosome shotgun sequencing. BMC Microbiol 2008;8:43 doi:10.1186/1471-2180-8-43.
147. Häussler S, Parsek MR. Bioflims 2009: New perspectives at the heart of surface-associated microbial communities. J Bacteriology 2010;192:2941-2949.
148. Kempf VAJ, Volkmann B, Schaller M, et al. Evidence of a leading role for VEGF in Bartonella henselae-induced endothelial cell proliferations. Cell Micro 2001;3:623-632.
149. Kempf VAJ, Krämer F. The role of Bartonella spp. in veterinary and human medicine with special emphasis on pathogenicity mechanisms. Euro J Comp Anim Pract 2008;18:274-279.
150. Buchmann AU, Kempf VAJ, Kershaw O, Gruber AD. Peliosis hepatis in cats is not associated with Bartonella henselae infections. Vet Patho 2010;47:163-166.
151. Anis EA, O'Neill SH, Newkirk KM, et al. Molecular characterization of the L1 gene of papillomaviruses in epithelial lesions of cats and comparative analysis with corresponding gene sequences of human and feline papilloma viruses. Am J Vet Res 2010;71:1457-1461.
152. Avensani F, Romanelli MG, Turci M, et al. Association of HTLV Tax proteins with TAK-1 binding protein 2 and RelA in calreticulin-containing cytoplasmic structures participates in Tax-mediated NF-K{green}B activation. Virology 2010;408:39-48.